InsidersTradesSigma
Track the Blue Water Biotech, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 1 June 2023 (Attribution). Among the most active insiders: Ramdeen Timothy R.. The full history is openly available.
Analysts rate Blue Water Biotech, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Blue Water Biotech, Inc. is a company focused on developing innovative biopharmaceutical solutions. It is listed on the XNAS market.